| ²é¿´: 165 | »Ø¸´: 1 | |||||
dylhdaר¼Ò¹ËÎÊ (ÖøÃûдÊÖ)
|
[ÇóÖú]
΢Æ×ÇóÖú ÒÑÓÐ1È˲ÎÓë
|
|
ë®´úÂȷ£º14.0,109.2,115.8,117.3,117.3,118.7,119.3,129.4,130.9,134.1,150.6,151.0,155.4,191.3 ÏàËÆ¶Èǰʮ¼´¿É£¬Ð»Ð»¡£ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
353Çóµ÷¼Á
ÒѾÓÐ8È˻ظ´
²ÄÁϹ¤³Ì302·ÖÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çó
ÒѾÓÐ3È˻ظ´
²ÄÁÏÓ뻯¹¤363ÇóÍÆ¼ö
ÒѾÓÐ4È˻ظ´
085602µ÷¼Á ³õÊÔ×Ü·Ö335
ÒѾÓÐ11È˻ظ´
081700ѧ˶£¬323·Ö£¬Ò»Ö¾Ô¸Öйúº£Ñó´óѧÇóµ÷¼ÁѧУ
ÒѾÓÐ12È˻ظ´
085410È˹¤ÖÇÄÜ ³õÊÔ316·Ö Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
285Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´
²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á
ÒѾÓÐ11È˻ظ´
wangkaibo123
ÈÙÓþ°æÖ÷ (Ö°Òµ×÷¼Ò)
kerry
-

ר¼Ò¾Ñé: +726 - PhEPI: 3
- Ó¦Öú: 1928 (½²Ê¦)
- ¹ó±ö: 0.598
- ½ð±Ò: 7869.1
- É¢½ð: 10156
- ºì»¨: 100
- Ìû×Ó: 3780
- ÔÚÏß: 1007.1Сʱ
- ³æºÅ: 2088618
- ×¢²á: 2012-10-26
- ÐÔ±ð: GG
- רҵ: ¿¹Ö×ÁöÒ©ÎïÒ©Àí
- ¹ÜϽ: ҩѧ
¡¾´ð°¸¡¿Ó¦Öú»ØÌû
¸Ðл²ÎÓ룬ӦÖúÖ¸Êý +1
|
²éѯģʽ£ºÄ£ºý²éѯ ̼Æ×Êý¾ÝÊäÈ룺 °´´ÓСµ½´ó˳ÐòÊäÈ룬Êý×Ö¼äÓÃÓ¢Îİë½Ç¶ººÅ(,)·Ö¸ôÀýÈ磺 21.4,30.4,37.4,73.2,73.7,125.6,126.6,139.6,140.2,168.2 ÈܼÁÑ¡Ï Æ¥ÅäÈݲ (Êý×Ö¸ñʽ£¬¿É×ÔÐÐÉ趨) ÏàËÆ¶È£º %(ÏàËÆ¶È>=50%) ²éѯ½á¹û£º¹²²éµ½371¸ö»¯ºÏÎï(²éѯ½á¹û½ö¹©²Î¿¼) 1 . 4-{[4-Chloro-6-(4-methylphenoxy)-1,3,5-triazin-2-yl]amino}-3-fluorobenzonitrile ÏàËÆ¶È:64.2% Chemistry & Biodiversity 2009 6 561-568 Synthesis of Fluorine-Containing Diaryltriazine Derivatives for in vitro Anti-HIV Evaluation against Wild-Type Strain Yuan-Zhen Xiong, Fen-Er Chen, Jan Balzarini, Erik De Clercq, and Christophe Pannecouque Structure 13C NMR ̼Æ×Ä£Äâͼ 2 . 1-(4'-hydroxyphenyl)-3-(2'',5''-dihydroxyphenyl)-1H-pyrazole-4-carboxaldehyde C16H12N2O4 ÏàËÆ¶È:64.2% Bioorganic & Medicinal Chemistry 2010 18 4338-4350 Novel pyrazole derivatives: Synthesis and evaluation of anti-angiogenic activity Michael S. Christodoulou, Sandra Liekens, Konstantinos M. Kasiotis, Serkos A. Haroutounian Structure 13C NMR ̼Æ×Ä£Äâͼ 3 . compound 17 ÏàËÆ¶È:64.2% Magnetic Resonance in Chemistry 1994 32 182-183 13C NMR spectra of allosteric effectors of hemoglobin Stanislaw Ostrowski, Waldemar Priebe and Thomas G. Burke Structure 13C NMR ̼Æ×Ä£Äâͼ 4 . 3-Cyano-6-(2-hydroxylphenyl)-5-(4-methylphenyl)-pyridin-2(1H)-one C19H14N2O2 ÏàËÆ¶È:64.2% Chinese Journal of Chemistry 2013 31 1027-1032 Synthesis of 5,6-Diarylpyridin-2(1H)-ones from Isoflavones Mulin Zhu, Zunting Zhang, Dong Xue, Jinfeng Qiao, Yong Liang and Stanislaw F. Wnuk Structure 13C NMR ̼Æ×Ä£Äâͼ 5 . (1E)-1-[3,5-Bis(benzoyloxy)phenyl]ethanone O-Phenyloxime C28H21NO5 ÏàËÆ¶È:60% Helvetica Chimica Acta 2009 92 1404-1412 Total Synthesis of (+)-Machaeriols B and C and of Their Enantiomers with a Cannabinoid Structure Hee Jin Lee, Yong Rok Lee, Sung Hong Kim Structure 13C NMR ̼Æ×Ä£Äâͼ 6 . compound 10a C15H13NO5 ÏàËÆ¶È:60% Journal of Heterocyclic Chemistry 2001 38 1459-1463 Benzopyrans. Part 42. Reactions of 4-Oxo-4H-1-benzopyran-3-carbaldehyde with some active methylene compounds in the presence of ammonia Chandra Kanta Ghosh, Anirban Ray and Amarendra Patra Structure 13C NMR ̼Æ×Ä£Äâͼ 7 . 5-((1H-Imidazol-1-yl)methyl)-2-(3,4-difluoro-phenyl)pyridine ÏàËÆ¶È:60% Bioorganic & Medicinal Chemistry 2008 16 1992-2010 Synthesis, biological evaluation and molecular modelling studies of methyleneimidazole substituted biaryls as inhibitors of human 17¦Á-hydroxylase-17,20-lyase (CYP17). Part I: Heterocyclic modifications of the core structure Carsten Jagusch, Matthias Negri, Ulrike E. Hille, Qingzhong Hu, Marc Bartels, Kerstin Jahn-Hoffmann, Mariano A.E. Pinto-Bazurco Mendieta, Barbara Rodenwaldt, Ursula M¨¹ller-Vieira, Dirk Schmidt, Thomas Lauterbach, Maurizio Recanatini, Andrea Cavalli, Rolf Structure 13C NMR ̼Æ×Ä£Äâͼ 8 . 3-[2-(2-thienyl)pyridin-4-yl]phenol ÏàËÆ¶È:60% Bioorganic & Medicinal Chemistry 2010 18 3494-3505 Novel estrone mimetics with high 17¦Â-HSD1 inhibitory activity Alexander Oster, Tobias Klein, Ruth Werth, Patricia Kruchten, Emmanuel Bey, Matthias Negri, Sandrine Marchais-Oberwinkler, Martin Frotscher, Rolf W. Hartmann Structure 13C NMR ̼Æ×Ä£Äâͼ 9 . 3-[2-(5-chloro-2-thienyl)pyridin-4-yl]phenol ÏàËÆ¶È:60% Bioorganic & Medicinal Chemistry 2010 18 3494-3505 Novel estrone mimetics with high 17¦Â-HSD1 inhibitory activity Alexander Oster, Tobias Klein, Ruth Werth, Patricia Kruchten, Emmanuel Bey, Matthias Negri, Sandrine Marchais-Oberwinkler, Martin Frotscher, Rolf W. Hartmann Structure 13C NMR ̼Æ×Ä£Äâͼ 10 . (2E)-1-(1,3-Benzodioxol-5-yl)-3-(5-methylfuran-2-yl)-2-propen-1-one C15H12O4 ÏàËÆ¶È:60% Journal of the Brazilian Chemical Society 2010 21 142-150 Biochemical Evaluation of a Series of Synthetic Chalcone and Hydrazide Derivatives as Novel Inhibitors of Cruzain from Trypanosoma cruzi Deise M. Borchhardt, Alessandra Mascarello, Louise Domeneghini Chiaradia, Ricardo J. Nunes, Glaucius Oliva, Rosendo A. Yunes and Adriano D. Andricopulo Structure 13C NMR ̼Æ×Ä£Äâͼ 11 . (2E,2'E)-1,1'-(5,5'-(piperazine-1,4-diylbis(methylene))bis(4-hydroxy-3-methoxy-5,1-phenylene))bis(3-(5-methylfuran-2-yl)prop-2-en-1-one) C36H38O8N2 ÏàËÆ¶È:58.8% Chemical & Pharmaceutical Bulletin 2011 59 1549-1554 Preparation of a Series of Novel Bichalcones Linked with a 1,4-Dimethylenepiperazine Moiety and Examination of Their Cytotoxicity Mopuru Vijaya Bhaskar Reddy, Shih-Shun Chen, Meng-Liang Lin, Hsiu-Hui Chan, Ping-Chung Kuo and Tian-Shung Wu Structure 13C NMR ̼Æ×Ä£Äâͼ 12 . 1-(3-hydroxy-7-acetylnaphthalen-2-yl)ethanone C14H12O3 ÏàËÆ¶È:57.1% Natural Product Research 2007 21 203-210 Antifungal agent and other constituents from Cynanchum otophyllum Yi-Bin Zhao; Yue-Mao Shen; Hong-Ping He; Quan-Zhang Mu; Xiao-Jiang Hao Structure 13C NMR ̼Æ×Ä£Äâͼ |

2Â¥2014-06-18 09:38:19














»Ø¸´´ËÂ¥
120